Kynetyka is delighted to welcome Peter Bradley to Kynetyka as Chief Operating Officer. Peter brings an incredible wealth of experience as a medtech developer and international commercialisation executive. He will take on responsibility for further developing Kynetyka’s DVTect® medical device, overseeing the work done by Kynetyka’s engineering and clinical partners. His resume covers senior exec roles at ASX-listed LBT Innovations (now ASX:CC5) and Innate Immunotherapeutics (now ASX:ATX), Clever Culture Systems, KODE Biotech (NZ), Australian Orthopaedic Innovations and CSL Limited. Peter brings great insight, high energy and a fantastic national and international network to this new role at Kynetyka. Welcome Peter!